Literature DB >> 22112344

Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study.

Abigail B Shoben1, Bryan Kestenbaum, Gregory Levin, Andrew N Hoofnagle, Bruce M Psaty, David S Siscovick, Ian H de Boer.   

Abstract

Low circulating concentrations of 25-hydroxyvitamin D (25(OH)D) are associated with adverse health outcomes in diverse populations. However, 25(OH)D concentrations vary seasonally with varying exposure to sunlight, so single measurements may poorly reflect long-term 25(OH)D exposure. The authors investigated cyclical trends in average serum 25(OH)D concentrations among 2,298 individuals enrolled in the Cardiovascular Health Study of community-based older adults (1992-1993). A sinusoidal model closely approximated observed 25(OH)D concentrations and fit the data significantly better than did a mean model (P < 0.0001). The mean annual 25(OH)D concentration was 25.1 ng/mL (95% confidence interval: 24.7, 25.5), and the mean peak-trough difference was 9.6 ng/mL (95% confidence interval: 8.5, 10.7). Male sex, higher latitude of study site, and greater physical activity levels were associated with larger peak-trough difference in 25(OH)D concentration (each P < 0.05). Serum concentrations of intact parathyroid hormone and bone-specific alkaline phosphatase also varied in a sinusoidal fashion (P < 0.0001), inversely to 25(OH)D. In conclusion, serum 25(OH)D varies in a sinusoidal manner, with large seasonal differences relative to mean concentration and laboratory evidence of biologic sequelae. Single 25(OH)D measurements might not capture overall vitamin D status, and the extent of misclassification could vary by demographic and behavioral factors. Accounting for collection time may reduce bias in research studies and improve decision-making in clinical care.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22112344      PMCID: PMC3276302          DOI: 10.1093/aje/kwr258

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  23 in total

1.  Vitamin D, parathyroid hormone, and cardiovascular events among older adults.

Authors:  Bryan Kestenbaum; Ronit Katz; Ian de Boer; Andy Hoofnagle; Mark J Sarnak; Michael G Shlipak; Nancy S Jenny; David S Siscovick
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

2.  Standards of medical care in diabetes--2007.

Authors: 
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

Review 3.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

4.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

Review 5.  Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes.

Authors:  Heike A Bischoff-Ferrari; Edward Giovannucci; Walter C Willett; Thomas Dietrich; Bess Dawson-Hughes
Journal:  Am J Clin Nutr       Date:  2006-07       Impact factor: 7.045

6.  Vitamin D status and related parameters in a healthy population: the effects of age, sex, and season.

Authors:  S S Sherman; B W Hollis; J D Tobin
Journal:  J Clin Endocrinol Metab       Date:  1990-08       Impact factor: 5.958

7.  Decreased bioavailability of vitamin D in obesity.

Authors:  J Wortsman; L Y Matsuoka; T C Chen; Z Lu; M F Holick
Journal:  Am J Clin Nutr       Date:  2000-09       Impact factor: 7.045

8.  Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.

Authors:  A Levin; G L Bakris; M Molitch; M Smulders; J Tian; L A Williams; D L Andress
Journal:  Kidney Int       Date:  2006-11-08       Impact factor: 10.612

9.  Serum parathyroid hormone level is associated with body mass index. The 5th Tromsø study.

Authors:  Elena Kamycheva; Johan Sundsfjord; Rolf Jorde
Journal:  Eur J Endocrinol       Date:  2004-08       Impact factor: 6.664

10.  25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III).

Authors:  Ian H de Boer; George N Ioannou; Bryan Kestenbaum; John D Brunzell; Noel S Weiss
Journal:  Am J Kidney Dis       Date:  2007-07       Impact factor: 8.860

View more
  52 in total

1.  Vitamin D deficiency and airflow limitation in the Baltimore Longitudinal Study of Ageing.

Authors:  Mia Moberg; Palchamy Elango; Luigi Ferrucci; Martijn A Spruit; Emiel F Wouters; Erica P A Rutten
Journal:  Eur J Clin Invest       Date:  2015-08-07       Impact factor: 4.686

Review 2.  Linking vitamin d deficiency to inflammatory bowel disease.

Authors:  Matthew T Palmer; Casey T Weaver
Journal:  Inflamm Bowel Dis       Date:  2013-09       Impact factor: 5.325

3.  Rationale and design of the Study To Understand Fall Reduction and Vitamin D in You (STURDY): A randomized clinical trial of Vitamin D supplement doses for the prevention of falls in older adults.

Authors:  Erin D Michos; Christine M Mitchell; Edgar R Miller; Alice L Sternberg; Stephen P Juraschek; Jennifer A Schrack; Sarah L Szanton; Jeremy D Walston; Rita R Kalyani; Timothy B Plante; Robert H Christenson; Dave Shade; James Tonascia; David L Roth; Lawrence J Appel
Journal:  Contemp Clin Trials       Date:  2018-08-20       Impact factor: 2.226

4.  Plasma 25-hydroxyvitamin D and risk of metabolic syndrome: an ancillary analysis in the Diabetes Prevention Program.

Authors:  J Mitri; J Nelson; R Ruthazer; C Garganta; D M Nathan; F B Hu; B Dawson-Hughes; A G Pittas
Journal:  Eur J Clin Nutr       Date:  2014-01-22       Impact factor: 4.016

5.  Seasonal variation of 25-hydroxyvitamin D among non-Hispanic black and white pregnant women from three US pregnancy cohorts.

Authors:  Miguel Angel Luque-Fernandez; Bizu Gelaye; Tyler VanderWeele; Cynthia Ferre; Anna Maria Siega-Riz; Claudia Holzman; Daniel A Enquobahrie; Nancy Dole; Michelle A Williams
Journal:  Paediatr Perinat Epidemiol       Date:  2013-12-20       Impact factor: 3.980

6.  Vitamin D and subclinical cerebrovascular disease: the Atherosclerosis Risk in Communities brain magnetic resonance imaging study.

Authors:  Erin D Michos; Kathryn A Carson; Andrea L C Schneider; Pamela L Lutsey; Li Xing; A Richey Sharrett; Alvaro Alonso; Laura H Coker; Myron Gross; Wendy Post; Thomas H Mosley; Rebecca F Gottesman
Journal:  JAMA Neurol       Date:  2014-07-01       Impact factor: 18.302

7.  Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Michael C Sachs; Abigail Shoben; Gregory P Levin; Cassy Robinson-Cohen; Andrew N Hoofnagle; Nancy Swords-Jenny; Joachim H Ix; Matthew Budoff; Pamela L Lutsey; David S Siscovick; Bryan Kestenbaum; Ian H de Boer
Journal:  Am J Clin Nutr       Date:  2013-04-24       Impact factor: 7.045

8.  Longitudinal changes and seasonal variations in serum 25-hydroxyvitamin D levels in different age groups: results of the Longitudinal Aging Study Amsterdam.

Authors:  N M van Schoor; D L Knol; D J H Deeg; F P A M N Peters; A C Heijboer; P Lips
Journal:  Osteoporos Int       Date:  2014-02-26       Impact factor: 4.507

9.  Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes.

Authors:  Gregory P Levin; Cassianne Robinson-Cohen; Ian H de Boer; Denise K Houston; Kurt Lohman; Yongmei Liu; Stephen B Kritchevsky; Jane A Cauley; Toshiko Tanaka; Luigi Ferrucci; Stefania Bandinelli; Kushang V Patel; Emil Hagström; Karl Michaëlsson; Håkan Melhus; Thomas Wang; Myles Wolf; Bruce M Psaty; David Siscovick; Bryan Kestenbaum
Journal:  JAMA       Date:  2012-11-14       Impact factor: 56.272

10.  Increasing serum 25-hydroxyvitamin D is associated with reduced odds of long menstrual cycles in a cross-sectional study of African American women.

Authors:  Anne Marie Z Jukic; Kristen Upson; Quaker E Harmon; Donna D Baird
Journal:  Fertil Steril       Date:  2016-03-18       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.